Want to join the conversation?
Medical technology company $BDX said it has unveiled BD FACSCelesta flow cytometer at the 2015 American Society for Cell Biology (ASCB) annual meeting. This new system offers simultaneous measurement of up to 14 different single cell characteristics and is designed to leverage the broad BD Horizon Brilliant reagent portfolio.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.